Wednesday, May 15, 2013

EASL Review Results -HCV Phase III Investigational Agents and Approved Agents

When relevant education-related material is released pertinent to HCV this blog points the reader to the new data and learning activity. 
Clinical Care Options recently launched a downloadable slideset which include review results from Phase III studies of HCV investigational agents and key studies of approved drugs telaprevir and boceprevir from the 2013 European Association for the Study of Liver.

Summary of Phase III Investigational Agents For HCV Discussed

*Free registration is required to download slides and view capsule summaries

No comments:

Post a Comment